Pain Relief Breakthrough Sends Stock Soaring

Heads up: Artelo Biosciences just saw its stock double after sharing good news about a new non-opioid pain treatment. If you know anyone dealing with nerve pain from chemo, this could be a game-changer. The drug showed only mild side effects in its first human trial, and the company’s now racing to the next phase. Investors are buzzing, but a word of caution—Artelo’s low on cash, so more stock sales could be coming. Worth watching if you’re into health stocks or just want to see what’s next for pain relief! #PainRelief #StockMarket #HealthInnovation #Business #Market